Off-Label Crisis Workshop Offers Real-World Solutions to Identify, Minimize Risky Practices
- Two-Day Workshop Scheduled for September in Philadelphia, PA
- Expert Instructors From McGuireWoods, Purdue Pharma, Deloitte
FALLS CHURCH, Va., Aug. 24 /PRNewswire/ -- FDAnews announced today a special two-day, hands-on workshop: THE OFF-LABEL CRISIS WORKSHOP: IDENTIFY AND ELIMINATE RISKY PRACTICES BEFORE IT'S TOO LATE This workshop is scheduled Sept. 20-21, 2005 at the Loews Philadelphia Hotel in Philadelphia, PA. It's a proactive way to secure your company before bad practices lead to investigations, prosecutions and lost profit. Learn from the only interactive two-day workshop exclusively designed to help you tackle this costly and growing problem. Even drug and device companies that haven't intentionally violated the law are being singled out for prosecution! This is NOT the time to be complacent! Register today for THE OFF-LABEL CRISIS WORKSHOP. Let expert litigators and compliance officers from McGuireWoods, Purdue Pharma and Deloitte help you identify and minimize your exposure. The workshop will focus on the emerging crisis drug and device firms face as federal and state prosecutors crack down on off-label promotion practices. WORKSHOP ATTENDEES WILL LEARN -- Key factors that trigger off-label promotion risks -- What you must know about federal and state initiatives in off-label crackdowns -- What the Federal False Claims Act really means to your operations -- How to structure effective internal reviews -- How to respond to government inquiries and investigations -- How to minimize penalties for violations -- both civil and criminal -- Best methods for dealing with whistle-blowers and wrongful discharge claims -- Proven strategies for continuous monitoring and improvement WORKSHOP TUITION Registration: $1,795. Tuition includes two days of training and interactive sessions, training materials (presentation slides and reference material), continental breakfast and lunch each day, and first evening reception. Online enrollment: http://www.fdanews.com/wbi/conferences/offlabelcrisis.html Phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600 Fax: +1 (703) 538-7676 PRESENTED BY FDANEWS FDAnews is the premier provider of global regulatory, legislative and business news and information for professionals in industries regulated by the FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' conferences, print and electronic newsletters, and books to stay in compliance with international standards and FDA's complex and ever-changing regulations. CONTACT: Jeff Grizzel Conference Director FDAnews 300 N Washington St Ste 200 Falls Church VA USA 22046 703-538-7600 phone http://www.fdanews.com
More by this Source
FDAnews Announces FDA's New Generic Drug Safety Labeling Rule Webinar, Dec. 9
Dec 05, 2013, 17:42 ET
FDAnews Announces Leverage Tools for Device CAPA Compliance Virtual Conference, Dec. 19
Dec 03, 2013, 09:01 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.